Workflow
3 Biotech Stocks You Should Know About
EXASExact Sciences(EXAS) Schaeffers Investment Research·2024-07-17 18:35

Core Insights - The SPDR S&P Biotech ETF (XBI) has shown strong performance, gaining 4% in June and 7.3% in July [1] Company Performance - EXACT Sciences Corporation (NASDAQ:EXAS) shares are down 1.1% to 49.14,despitea2149.14, despite a 21% recovery from its June 25 low of 40.62, but are still 33.5% lower year-to-date in 2024 [1] - Sarepta Therapeutics Inc (NASDAQ:SRPT) stock is down 1.8% to 146.16,havingdecreased15.5146.16, having decreased 15.5% from its June 21 high of 173.25, yet remains up 51.6% year-to-date [1] - United Therapeutics Corp. (NASDAQ:UTHR) stock reached a record high of 339.56,followingapricetargetincreasefromLeerinkto339.56, following a price-target increase from Leerink to 344, and is up 51.6% in 2024, trading at $333.44 [1]